No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Combined Modality Therapy
-
Esophageal Neoplasms / mortality
-
Esophageal Neoplasms / pathology*
-
Esophageal Neoplasms / therapy*
-
Humans
-
Lymphatic Metastasis
-
Neoplasm Staging
-
Palliative Care
-
Prognosis
-
Survival Rate